Zobrazeno 1 - 10
of 214
pro vyhledávání: '"Adalimumab therapy"'
Publikováno v:
Case Reports in Dermatology, Vol 10, Iss 2, Pp 145-148 (2018)
Bullous pemphigoid (BP) is a blistering autoimmune disease mainly observed in elderly patients. Several triggers are known for this autoimmune disease and some drugs are known to be a cause of BP. However, there are only few case reports on the induc
Externí odkaz:
https://doaj.org/article/82565046199b470c8ace2e6f52b60eb9
Publikováno v:
Advances in Digestive Medicine. 10:28-33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d542dcacc4a2b1e08ae61d9d6fd5cc9
https://doi.org/10.1002/aid2.13300
https://doi.org/10.1002/aid2.13300
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Caroline S. Jiang, Neha Singh, John W. Frew, Kristina Navrazhina, Roger D. Vaughan, James G. Krueger, David Grand
Publikováno v:
Clinical and Experimental Dermatology. 45:859-865
Background The association of adalimumab therapy with malignancy and infection is established in other inflammatory diseases; however, rates of hidradenitis suppurativa (HS) are based on case reports or retrospective healthcare data and the effect of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9fe02e90fba66486d5009f2d9ce8b83
https://doi.org/10.1111/ced.14264
https://doi.org/10.1111/ced.14264
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 13, Iss 3, Pp 547-554 (2020)
Clinical and Translational Science, Vol 13, Iss 3, Pp 547-554 (2020)
This study aimed at exploring the concentration‐effect relationship of adalimumab and early adalimumab and anti‐adalimumab antibody (AAA) levels in predicting primary nonresponse in a real‐world pilot cohort of patients with ankylosing spondyli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5369e26b8b0e1496ab4a94b916bff9a3
https://doi.org/10.1111/cts.12738
https://doi.org/10.1111/cts.12738
Publikováno v:
Annales de Dermatologie et de Vénéréologie. 146:817-820
Resume Introduction La meningoccemie subaigue ou chronique est une infection invasive a Neisseria meningitidis caracterisee cliniquement par une fievre prolongee de plusieurs jours (subaigue) ou d’au moins sept jours (chronique), une eruption cutan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0d0b0b78082a00b1887c5058af3331d
https://doi.org/10.1016/j.annder.2019.08.014
https://doi.org/10.1016/j.annder.2019.08.014
Publikováno v:
Eur J Breast Health
Idiopathic granulomatous mastitis (IGM) is a rare, benign, inflammatory breast disease that primarily affects parous women within a period of five years post-partum. Cystic neutrophilic granulomatous mastitis (CNGM) is clinically identical to IGM, bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34eaee3cf74cf90857f938f18c73182b
https://europepmc.org/articles/PMC8734519/
https://europepmc.org/articles/PMC8734519/
Publikováno v:
Cutis. 108
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f00c305f59cd259e33dd844342fefcef
https://doi.org/10.12788/cutis.0366
https://doi.org/10.12788/cutis.0366
Autor:
Linkai Fang, Xuqi Zheng, Jieruo Gu, Xiaomin Li, Jialing Wu, Qiujing Wei, Zena Chen, Xi Zhang, Ou Jin, Xinyu Wu
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
Growing evidence suggests that the gut microbiota is involved in the initiation and progression of ankylosing spondylitis (AS). In this study, we aimed to explore the gut microbiome alterations during adalimumab therapy and verify microbiome biomarke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7b2ea46fce797eecd8ec4335494ac72